ADIM
ACN icon

Alpha DNA Investment Management’s Accenture ACN Stock Holding History

Alpha DNA Investment Management’s Portfolio ACN Stock Details ACN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,510
Closed -$4.75M – 13
2024
Q4 		$4.75M Buy
13,510
+10,364
+329% +$3.73M 1.81% 7
2024
Q3 		$1.11M Sell
3,146
-43
-1% -$14.1K 0.42% 47
2024
Q2 		$968K Buy
3,189
+547
+21% +$168K 0.38% 52
2024
Q1 		$916K Sell
2,642
-3,056
-54% -$1.11M 0.34% 61
2023
Q4 		$2M Buy
5,698
+2,339
+70% +$754K 0.78% 19
2023
Q3 		$1.03M Sell
3,359
-3,906
-54% -$1.23M 0.42% 47
2023
Q2 		$2.24M Buy
7,265
+160
+2% +$46.5K 0.75% 16
2023
Q1 		$2.03M Buy
7,105
+3,193
+82% +$870K 0.6% 18
2022
Q4 		$1.04M Sell
3,912
-667
-15% -$184K 0.37% 113
2022
Q3 		$1.18M Buy
+4,579
New +$1.32M 0.98% 24
2021
Q2 		– Sell
-222
Closed -$61K – 107
2021
Q1 		$61K Sell
222
-3
-1% -$775 0.07% 146
2020
Q4 		$58K Buy
+225
New +$53.9K 0.06% 160

Other funds holding ACN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alpha DNA Investment Management's ACN Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Accenture (ACN) in Q1 2025, closing a stake of 13,510 shares — an estimated $4.75M sold.

Alpha DNA Investment Management first reported a position in ACN in Q4 2020 and held it in 12 quarters. The position peaked at $4.75M in Q4 2024. 2,432 funds tracked by Wall St. Rank hold ACN as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Accenture position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 13,510 Accenture shares in Q1 2025, an estimated $4.75M.
  • Alpha DNA Investment Management first reported a position in Accenture in Q4 2020 and held it in 12 quarters.
  • Alpha DNA Investment Management's Accenture position peaked at $4.75M in Q4 2024.
  • 2,432 funds tracked by Wall St. Rank held Accenture as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.